vinayakkprasad.com
May 9, 2025, 07:02
Vinay Prasad Appointed as the New Head of FDA’s Center for Biologics Evaluation and Research
Martin Makary, 27th Commissioner of the U.S. FDA, shared a post on X:
“I’m proud to welcome Dr. Vinay Prasad, MD, MPH, as the new head of FDA’s Center for Biologics Evaluation and Research.
With 500+ peer-reviewed publications and two books, Dr. Prasad brings the kind of scientific rigor, independence, and transparency we need at CBER—a significant step forward.
Welcome aboard, Dr. Prasad.”
Timothée Olivier, Medical oncologist at the Oncology Division of Geneva University Hospital, shared this post, adding:
“I can attest Vinay is one of the greatest thinkers of our time, together with immense humanity and common sense. I couldn’t think of a more beautiful and relevant choice.
Congrats to you, Vinay.
Congrats to Marty for this choice !”
More posts featuring Vinay Prasad.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 9, 2025, 18:18
Sep 9, 2025, 17:59
Sep 9, 2025, 17:43
Sep 9, 2025, 16:51
Sep 9, 2025, 15:59